Xarelto
ICER Reviews BMS’ Eliquis, J&J’s Xarelto Amidst Medicare Price Talks
Anika Sharma
As the United States embarks on a new era of drug price negotiations, the Institute for Clinical and Economic Review ...
Anthos’ ABP-959 outperforms Xarelto in preventing bleeding events in phase 2 trial
Anika Sharma
Blackstone Life Sciences’ substantial $250 million investment in an ex-Novartis drug candidate has yielded yet another positive outcome in its ...
